A groundbreaking retrospective cohort study conducted at a leading tertiary academic medical center, encompassing a vast sample size of 36,993 adult patients undergoing primary TJA from 2016 to 2021, represents one of the most comprehensive analyses to date examining weight trajectories post-joint replacement. This investigation meticulously recorded patients’ body mass index (BMI) and weight at the time of surgery and subsequently at standard three-month postoperative intervals, allowing a granular assessment of temporal weight changes with stratification by preoperative BMI categories: under 25, 25 to under 30, 30 to under 35, 35 to under 40, and 40 kg/m² or greater. The scale and duration of the follow-up provided an unprecedented opportunity to discern subtle trends and patterns across different weight strata.

The findings of this extensive analysis elucidate a nuanced weight profile following both THA and TKA procedures. In the immediate postoperative period spanning one to three months, modest reductions in BMI were observed—averaging approximately a 0.55% decrease for hip replacements and a slightly higher 1.15% decrease for knee replacements. These early decreases in BMI may reflect factors such as perioperative metabolic adjustments, postoperative fluid shifts, or decreased caloric intake during initial recovery phases rather than true fat mass loss driven by enhanced activity. Importantly, these short-term reductions, although statistically detectable, were considerably more limited in magnitude than conventional clinical expectations might predict.

As the postoperative period extended beyond the initial quarter, the trajectory of weight change substantially shifted. By the 13- to 15-month interval, the net change in BMI almost reverted to baseline for patients undergoing THA, with only a negligible 0.09% reduction remaining. Patients undergoing TKA fared marginally better but still saw weight changes approach pre-surgical levels, with an average BMI decline of just 0.65%. This pattern of weight rebound underscores a critical finding: the early postoperative weight loss observed is transient and does not typically translate into lasting, clinically meaningful reductions in body mass. The temporary nature of weight loss after joint arthroplasty challenges prevailing assumptions about the surgery’s role as a catalyst for durable weight management.

The study’s stratification by baseline BMI revealed an intriguing pattern among patients with severe obesity—defined as BMI values of 40 kg/m² or higher. This subgroup displayed the most pronounced initial reduction in BMI, averaging a 1.30% decrease at 1–3 months post-surgery. However, this early improvement did not persist; by 13–15 months, these individuals exhibited a rebound effect, gaining weight to slightly surpass their initial BMI by approximately 0.21%. This rebound phenomenon suggests that while some obese patients may initially shed excess weight, potentially from the combined effect of surgical stress and altered behavior during recovery, sustaining this loss amidst metabolic, behavioral, and biomechanical challenges proves difficult.

Looking holistically across all BMI groups, the absolute magnitude of both BMI and body weight changes remained minimal throughout the postoperative year. A critical inflection point was identified between seven and nine months after surgery, marking a turning point where patients generally transitioned from modest weight reduction or stabilization toward gradual weight regain. This timing aligns with the waning of acute postoperative restrictions and the resumption of habitual lifestyle patterns, implying that the absence of structured, integrated weight management interventions limits patients’ capacity to achieve and maintain weight loss following TJA.

The implications of these findings resonate widely within orthopedic, obesity, and rehabilitation domains. The absence of significant, sustained postoperative weight loss following TJA challenges the prevailing narrative that joint replacement surgery inherently induces favorable metabolic and weight outcomes via enhanced mobility. Instead, the data advocate for the routine inclusion of comprehensive perioperative weight management protocols that extend beyond the surgical episode. Multidisciplinary approaches encompassing nutritional counseling, behavioral therapy, physical activity promotion, and perhaps pharmacologic interventions may be crucial to truly harness the functional improvements gained from TJA and convert them into lasting metabolic health benefits.

Moreover, the data have high clinical relevance to preoperative patient counseling. Surgeons and allied health professionals should temper expectations regarding weight loss post-TJA and discuss realistic outcomes with patients, particularly those with obesity, who may anticipate the surgery as a means of weight reduction. Recognizing the transient and limited nature of weight changes after surgery can foster more informed shared decision-making and encourage active patient engagement in adjunctive lifestyle modification programs.

Further research is essential to unravel the mechanisms underpinning the observed weight trajectories. Disentangling the roles of postoperative pain, physical activity levels, nutritional intake, psychological factors, and metabolic adaptability will be critical. Additionally, exploring personalized interventions tailored to BMI substrata could identify effective strategies to optimize weight management outcomes post-arthroplasty.

This landmark study highlights the complex interplay between musculoskeletal health, surgical intervention, and metabolic regulation. By leveraging an unprecedented analytical scale and methodological rigor, it reframes our understanding of the weight consequences of joint replacement surgery. Ultimately, these insights contribute to evolving best practices that align surgical success with broader health goals, paving the way for more holistic patient care paradigms that integrate orthopedics, metabolic health, and rehabilitation science.

As the burden of obesity and osteoarthritis continues to rise globally, elucidating the subtle dynamics of postoperative weight change becomes increasingly vital. The integration of weight management into the perioperative care of TJA patients could not only magnify the functional benefits of surgery but also mitigate risks of comorbidities, reduce mechanical joint load, and enhance long-term prosthesis survival. This study forms a foundational evidence base, challenging assumptions and catalyzing future innovation in the comprehensive management of patients undergoing joint replacement surgery.

In summary, while total hip and knee arthroplasty unequivocally deliver improved mobility and life quality, their capacity to produce meaningful, lasting weight loss is limited. Early postoperative BMI reductions are modest and transient, with most patients eventually reverting to their original weight or gaining weight above baseline, especially those with severe obesity. These nuanced findings underscore the imperative for integrated and sustained perioperative weight management strategies to optimize patient outcomes and fully realize the health potential of joint arthroplasty.

Subject of Research: Weight and BMI changes following total hip and knee arthroplasty surgeries, with a focus on long-term postoperative weight trajectories stratified by baseline BMI.

Article Title: Is lower extremity joint replacement surgery associated with weight loss? An institutional retrospective study of 36,993 cases.

Article References:
Ren, R., Giannakis, P., Zhong, H. et al. Is lower extremity joint replacement surgery associated with weight loss? An institutional retrospective study of 36,993 cases. Int J Obes (2026). https://doi.org/10.1038/s41366-025-02014-x

Image Credits: AI Generated

DOI: 03 January 2026

Keywords: Total joint arthroplasty, total hip arthroplasty, total knee arthroplasty, weight loss, BMI change, obesity, postoperative weight trajectory, perioperative weight management, functional mobility, longitudinal cohort study

Osteoarthritis, a progressive joint disease largely characterized by cartilage degradation and resultant pain, especially in load-bearing joints like the knee, affects millions globally. Traditional management emphasizes physical exercise due to its efficacy in pain relief and functional enhancement. However, barriers such as limited accessibility to in-person programs deter widespread participation. Herein, this study offers a compelling alternative through a multimodal online tai chi regimen capable of overcoming these obstacles.

Tai chi, an ancient Chinese martial art involving slow, deliberate movements and controlled breathing, has increasingly gained recognition in medical communities for its neuromuscular benefits and pain-modulating properties. By integrating tai chi into an online, unsupervised format, the trial taps into both biophysical mechanisms inherent to the practice and the flexibility afforded by digital platforms, offering a potentially transformative treatment option.

The randomized clinical trial rigorously evaluated this intervention over 12 weeks, comparing outcomes between participants engaging in the tai chi program and those receiving usual care. Outcome measures focused predominantly on knee pain intensity and function, employing validated scales common in osteoarthritis research. Statistical analyses underscored significant improvements in the intervention arm, demonstrating clinical and practical relevance.

Importantly, the study’s methodology ensured robust randomization procedures to minimize selection bias, leveraging statistical theory principles to underpin group allocation. This approach bolstered the credibility of findings and reinforced the scientific rigor of the trial. Moreover, the incorporation of digital tools enabled real-time monitoring and adherence tracking, despite the unsupervised nature of the program.

The intervention’s design capitalized on computer networking and internet technologies to deliver content, host interactive modules, and facilitate virtual support communities. Such integration not only addressed the logistical challenges posed by in-person therapy sessions but also tapped into evolving digital health frameworks, emphasizing scalability and cost-effectiveness without compromising quality or safety.

Mechanistically, the trial posits that tai chi’s emphasis on balance, muscular strength, and proprioception may restore functional biomechanics in osteoarthritic knees, particularly influencing structures like the patella. Additionally, rhythmic movement patterns likely mediate anti-inflammatory effects and pain perception modulation through neuroimmune pathways, aligning with current understanding of inflammatory arthritis pathophysiology.

Pain reduction stood as a cornerstone outcome, with patients reporting diminished symptom severity and enhanced daily function. These findings resonate with broader clinical medicine principles, wherein nonpharmacological interventions form a cornerstone of chronic disease management. Moreover, the study underscores tai chi’s potential for integration within multidisciplinary treatment algorithms for osteoarthritis.

From a public health perspective, the intervention’s accessibility and lack of supervision requirements markedly lower barriers to exercise adherence, traditionally a significant challenge in chronic musculoskeletal conditions. This democratization of therapy aligns with contemporary policy goals aimed at extending effective care to underserved populations through innovative modalities.

Financial disclosures and conflict of interest statements accompanying the article affirm the independence of the research, emphasizing its unbiased contribution to osteoarthritis literature. Funding support also reflects institutional commitment to advancing digital health interventions, a growing area intersecting applied sciences, computer science, and clinical research.

Looking ahead, this trial sets a precedent for expanding the scope of multimodal online interventions targeting musculoskeletal and inflammatory disorders. As digital health continues to evolve, the seamless integration of therapeutic exercise regimens may become a staple in internal medicine and beyond, potentially reshaping chronic disease management frameworks.

To explore this paradigm-shifting study further, inquiries can be directed to the corresponding author, Dr. Kim L. Bennell, at the University of Melbourne’s Department of Physiotherapy. The full article posted in JAMA Internal Medicine offers a comprehensive account of the methodology, statistical models employed, and nuanced clinical implications that enrich the osteoarthritis treatment landscape.

In summary, this groundbreaking study provides compelling evidence that an unsupervised, web-based tai chi program significantly reduces knee pain and improves function over 12 weeks in people with osteoarthritis. Its accessible, scalable, and evidence-based design exemplifies the innovative potential of digital health interventions to meet current and future clinical needs.

Subject of Research: Osteoarthritis knee pain and function improvement through a multimodal online tai chi intervention
Article Title: Not specified in the provided content
News Publication Date: Not specified in the provided content
Web References: Not available
References: (doi:10.1001/jamainternmed.2025.5723)
Image Credits: Not provided

Keywords: Osteoarthritis, Patella, Disease intervention, Randomization, Clinical trials, Computer networking, Internet, Pain, Internal medicine, Physical exercise

Osteoarthritis triggers a cascade of pathological changes in the knee joint, prominently including inflammation caused by the degradation of cartilage and surrounding tissues. This inflammation stimulates the formation of abnormal blood vessels—a process known as angiogenesis—which increases blood flow to the joint. These newly formed vessels facilitate the migration of immune cells that exacerbate inflammation and contribute to persistent pain. Genicular artery embolization targets this vascular remodeling, aiming to mitigate the pathological blood flow feeding the inflamed synovium lining the knee.

The procedure involves the targeted delivery of biocompatible hydrogel beads through an image-guided catheter inserted via a tiny incision in the thigh. These microspheres selectively occlude up to half a dozen arteries supplying the synovium, effectively cutting off the pathological blood supply and interrupting the inflammatory signaling pathways. In the recent study, over 60% of the 25 patients undergoing this therapy in Manhattan reported marked improvements in pain, function, and stiffness one year post-procedure, highlighting the clinical potential of this approach.

Published online on August 12, 2025, in the Journal of Vascular and Interventional Radiology, this prospective single-arm trial closely monitored symptomatic patients with moderate to severe knee osteoarthritis unresponsive to conventional treatments such as corticosteroid injections, arthrocentesis, platelet-rich plasma therapy, and physiotherapy. Patient-reported outcomes, including standardized surveys assessing pain, stiffness, and mobility, were coupled with biomarker analyses to objectively evaluate treatment success.

One of the most compelling findings was the significant decline in serum levels of vascular endothelial growth factor (VEGF) observed at one-year follow-up, with an average reduction of 12%. VEGF is a pivotal protein driving angiogenesis, and its decline suggests that genicular artery embolization may directly alter the pathological vascular and inflammatory milieu within the osteoarthritic joint. Similarly, levels of interleukin 1 receptor antagonist (IL-1Ra), a key modulator of inflammation, decreased by 15%, further underscoring the anti-inflammatory effects of this intervention.

Dr. Ryan Hickey, associate professor and section chief of vascular and interventional radiology at NYU Grossman School of Medicine, emphasized the broader implications of the findings. He noted that genicular artery embolization not only provides symptomatic relief but might also influence the natural history of osteoarthritis by modifying underlying disease processes. The minimally invasive nature and favorable safety profile, with mild and transient side effects limited to localized skin discoloration and minor incision discomfort, render it particularly appealing to patients contraindicated for surgery.

Patients selected for this study ranged in age from 50 to 78 years, encompassing individuals for whom total knee replacement might be premature or medically risky due to comorbidities such as obesity, uncontrolled diabetes, cardiovascular disease, or tobacco use. This procedure fills a critical therapeutic void, offering a viable alternative for those in intermediate disease stages who have failed first-line therapies.

The technical execution of genicular artery embolization leverages advanced imaging techniques—primarily fluoroscopy—to guide catheters through the femoral artery to target knee vessels precisely. The delivery of embolic material is carefully calibrated to avoid ischemic damage to surrounding tissues, underscoring the expertise required in interventional radiology to navigate the intricate vascular anatomy of the knee.

In addition to clinical assessments, the study underscores the value of incorporating biochemical biomarkers such as VEGF as objective measures of treatment efficacy. Unlike subjective pain scales, these blood tests quantify molecular changes reflective of underlying pathophysiology, potentially serving as benchmarks for future clinical trials and long-term monitoring.

The research team, led by principal investigator Dr. Bedros Taslakian, now vice chair for research at the University of Miami Miller School of Medicine, highlighted the need for larger, randomized controlled trials to validate these findings and determine the longevity of benefits derived from embolization. Understanding patient-specific predictors for response will be crucial to refining indications and optimizing outcomes.

Further investigations are underway to elucidate the precise molecular and cellular mechanisms by which vascular occlusion translates into reduced joint inflammation and pain relief. Insights gained could pave the way for combination therapies or refinements in embolic materials to enhance the durability and scope of clinical benefits.

As osteoarthritis continues to impose a growing burden on healthcare systems — with approximately 24 million new knee cases diagnosed annually in the United States alone — the development of safe, effective, and minimally invasive treatment modalities like genicular artery embolization holds transformative potential. This intervention may ultimately delay or reduce the need for joint replacement surgeries, improving quality of life for a vast patient population.

In summary, the NYU Langone Health study propels genicular artery embolization into the spotlight as a promising therapeutic frontier in osteoarthritis management. Through strategic vascular intervention and evidence-based biomarker monitoring, this technique unlocks new possibilities to address chronic pain and joint degeneration that have long challenged clinicians and patients alike.

Subject of Research: People

Article Title: A Prospective Single-Arm Trial of Genicular Artery Embolization for Symptomatic Knee Osteoarthritis: Clinical and Biomarker Outcomes

News Publication Date: 12-Aug-2025

Web References: http://dx.doi.org/10.1016/j.jvir.2025.08.009

References:
Taslakian B, Hickey R, et al. A Prospective Single-Arm Trial of Genicular Artery Embolization for Symptomatic Knee Osteoarthritis: Clinical and Biomarker Outcomes. Journal of Vascular and Interventional Radiology. 2025 Aug 12. DOI: 10.1016/j.jvir.2025.08.009.

Keywords: Osteoarthritis, Genicular Artery Embolization, Interventional Radiology, Angiogenesis, Vascular Endothelial Growth Factor, Inflammation, Knee Pain, Minimally Invasive Treatment